IPMN was first differentiated from mucin-producing cystic neoplasms by Ohashi and Murakami in 1990 [18]; before this, the detection rate of IPMNs was only 3% [19]. Here, MUC5AC is linked to pancreatic intraductal papillary-mucinous neoplasm.